Navigation Links
China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
Date:3/25/2008

GUANGZHOU, China, March 25 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading developer and distributor of prescription and over the counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, medical devices, and medical formulations today announced that it will conduct a conference call at 9:00 a.m. Eastern Time on Thursday, March 27, 2008 to discuss the fourth quarter and fiscal year 2007 results.

Joining Mr. Shensan Yang, Chairman and Chief Executive Officer of China Medicine, will be Ms. Huizhen Yu, Chief Financial Officer. The Company plans to make an earnings announcement prior to the call.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 888- 419-5570. International callers should dial 617-896-9871, Conference Passcode: 25022850.

If you are unable to participate in the call at this time, a replay will be available for fourteen days starting on Thursday, March 27 at 11:00 a.m. Eastern Time. To access the replay, dial 888-286-8010, international callers dial 617-801-6888, Passcode: 92139283.

About China Medicine Corporation

China Medicine Corporation is a leading pharmaceutical company which discovers, develops, and distributes over 2,200 pharmaceutical products in China including prescription and over the counter ("OTC") drugs, traditional Chinese medicine ("TCM") products, herbs and dietary supplements. The Company distributes the products to wholesale distributors in 28 provinces, over 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for many uses including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website at

SOURCE China Medicine Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... and myeloproliferative disorders are serious and often deadly ... Annual Meeting of the American Society of Hematology ... methods for patients suffering from acute promyelocytic leukemia, ... myelofibrosis that are based on a better understanding ...
(Date:12/5/2009)... innovative new international private medical insurance plan which follows the acclaimed ... the flexibility to add or remove a wide range of options ... tailor their benefits to complement those already offered in their country ... ...
(Date:12/4/2009)... Investment Trust Inc. (NYSE: CRE ) ("Care" or ... a dividend of $0.17 per share of common stock. The ... record on December 14, 2009. ,, About ... real estate investment and finance company investing in healthcare-related real estate ...
(Date:12/4/2009)... Association of Homes and Services for the Aging (AAHSA) applauds ... Supportive Services (CLASS) provisions remain in the final health reform ... to elders, people with disabilities and their caregivers. ,, ... bill that will make it affordable to care for families ...
(Date:12/4/2009)... Bowen, Chief Information Officer at Crescent Healthcare, was selected ... Award for transforming Crescent,s business with the power of ... their innovative usage of Salesforce CRM or the Force.com ... their sales, marketing, partner, service, support or IT organizations. ...
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
... have been accomplished by people who have kept on trying when ... Carnegie ,A groundbreaking venture has ... in cancer-treatment, are mass-produced in the egg white of a certain ... is one of the leading causes of death in the ...
... known as microchimerism has been known for some years, that ... pregnancy, and that these may live on for many// years, ... still unclear as to whether the presence of such cells ... team has looked for maternal cells in children with type ...
... point to yet another benefit of statins; improving survival in ... heart patients. They work by lowering the levels of LDL ... ,The drugs have also been shown to help ... disease from having a heart attack or stroke. ...
... Food and Drug Administration has found that meat or milk ... these clones—is as safe to eat as food from// conventionally ... on three documents regarding the safety of animal cloning—a draft ... guidance for industry. ,Dr. Stephen F. Sundlof, director ...
... Northern Territory's Health Department Experts have warned about the ... central Australia.// ,There have been 10 cases ... of Central Australia during the past decade, including one ... last week's torrential downpours, locals and visitors have been ...
... Bilcare, a leading research-based pharmaceutical packing solution ... with Honeywell//, a UK-based pharma packaging firm, ... pharmaceutical sector. ,"The partnership with Honeywell's ... provide state-of-the-art materials for ensuing safety of ...
Other Medicine News:Health News:'Hen Factories' To Synthesize Cancer Drugs 2Health News:Stem Cells Passed From Mother to Child Live On and Make Insulin 2Health News:Statins Aid Survival in Lung Patients, Say Experts 2Health News:FDA Finds Animal Cloned Food to Be Safe 2
(Date:12/4/2009)... 4 Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") ... Patent and Trademark Office has allowed its patent application ... of the manufacture of the Company,s DCVax® therapeutic cancer ... the very high concentration of dendritic cells (which are ...
(Date:12/3/2009)... Allen Medical Systems, a subsidiary of Hill-Rom Holdings, ... launch of its new Allen Amatech(TM) OEM (Original Equipment ... ,, The website reinforces the Allen Amatech(TM) brand identity ... catalog, with detailed descriptions and design specifications for the ...
(Date:12/3/2009)... and CEO of The Quigley Corporation, (Nasdaq: QGLY ... has completed its evaluation of its opportunities to develop ... it is in its best interests to focus primarily ... are not limited to its Cold-EEZE® and Kids-EEZE® brands, ...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Linkwell Corporation Announces Launch of the Series of Handwashing Contest Across China 55285 1Linkwell Corporation Announces Launch of the Series of Handwashing Contest Across China 55285 2Linkwell Corporation Announces Launch of the Series of Handwashing Contest Across China 55285 3B Braun Named Supplier of the Year by McKesson 55284 1B Braun Named Supplier of the Year by McKesson 55284 2Hospice Foundation of America Presents New Educational Webinar on Supporting People with Intellectual Disabilities through Illness Grief and Loss 55282 1Hospice Foundation of America Presents New Educational Webinar on Supporting People with Intellectual Disabilities through Illness Grief and Loss 55282 2Hospice Foundation of America Presents New Educational Webinar on Supporting People with Intellectual Disabilities through Illness Grief and Loss 55282 3
... for,SB-509 in Development for Treatment of Diabetic ... Sangamo,BioSciences, Inc. announced today the presentation of ... Therapeutic(TM) program at the,67th Scientific Sessions of ... an oral presentation entitled, "Improved,Neurologic Exam and ...
... CITY, Calif.--(BUSINESS WIRE)--June 25, 2007--Gilead,Sciences, Inc. (Nasdaq:GILD) ... clinical trial evaluating the company's once-daily,anti-HIV drug ... mg as a potential treatment for chronic ... efficacy endpoint. The data show,that Viread is ...
Other Medicine Technology:Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 2Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 3Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 4Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 5Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 6Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 7Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 8Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 9Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6
... Rochester Medical's line of ... intermittent catheters you would ... four product configurations - ... antibacterial hydro - are ...
The Freedom Clear catheter is a 100% latex-free, self-adhering, one piece catheter with an ultra-thin sheath for every day wear....
... Natural® all-silicone non-adhesive male external catheter ... of latex-related allergic reactions. It is ... to change external catheters several times ... Natural catheter comes with an adjustable ...
Used as a percutaneous entry needle to introduce wire guides. The coaxial design reduces potential A.V. malformations. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: